+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency



Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency



Human Molecular Genetics 5(12): 1925-1930



An infant girl with elevated blood lactate, pyruvate, and plasma branched-chain amino acids was diagnosed with dihydrolipoamide dehydrogenase (E3; dihydrolipoamide:NAD+ oxidoreductase, EC 1.8.1.4) deficiency. Activities of the pyruvate dehydrogenase complex and E3 from patient were 26 and 2% of controls in blood lymphocytes, and 11 and 14% in cultured skin fibroblasts, respectively. Western blot analysis demonstrated that the amount of E3 protein in fibroblasts from the patient and her father was about half of controls, while Northern blot analysis showed normal amounts of E3 RNA. DNA sequencing of cloned full-length E3 cDNAs from the patient revealed two mutations in separate alleles. One is a single base insertion of an extra adenine in the last codon of the leader peptide sequence (TAC fwdarw TAAC) leading to a nonsense mutation which results in the premature termination of the precursor E3 polypeptide (Y35X). The other is a missense mutation due to substitution of guanine for adenine, causing an Arg fwdarw Gly substitution at amino acid 460 of the mature protein (R460G) which triggers the loss of E3 activity probably by structural change in the E3 dimer. DNA sequencing of E3 cDNAs from the parents demonstrated that the nonsense mutation was inherited from the father and the missense mutation was inherited from the mother.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008811860

Download citation: RISBibTeXText

PMID: 8968745

DOI: 10.1093/hmg/5.12.1925


Related references

Novel compound heterozygous mutation in a boy with dihydrolipoamide dehydrogenase deficiency. Journal of Inherited Metabolic Disease 23(Supplement 1): 152, July, 2000

A case of very-long-chain acyl-coenzyme A dehydrogenase deficiency with novel compound heterozygous mutations. Journal of the Neurological Sciences 368: 165-167, 2016

Mutations in the medium-chain acyl-CoA dehydrogenase gene in compound heterozygous patients with MCAD-deficiency. American Journal of Human Genetics 51(4 SUPPL ): A164, 1992

New compound heterozygous mutations of p. Thr101Ilefs 2 and p. Thr306Ale in a child from a Chinese family with 17α-hydroxylase/17, 20-lyase deficiency. Genetics and Molecular Research 14(3): 9318-9324, 2016

A novel and a previously described compound heterozygous PKLR gene mutations causing pyruvate kinase deficiency in a Chinese child. Fetal and Pediatric Pathology 33(3): 182-190, 2014

Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency. Orphanet Journal of Rare Diseases 7(): 90-90, 2013

Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states. Journal of Clinical Endocrinology and Metabolism 92(6): 2223-2231, 2007

Novel mutations in a boy with dihydrolipoamide dehydrogenase deficiency. Medical Science Monitor 7(6): 1319-1325, 2001

Compound heterozygous protein C deficiency in a family with venous thrombosis: Identification and in vitro study of p.Asp297His and p.Val420Leu mutations. Gene 563(1): 35-40, 2015

Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation. European Journal of Pediatrics 162(10): 714-718, 2003

Novel mutations in dihydrolipoamide dehydrogenase deficiency in two cousins with borderline-normal PDH complex activity. American Journal of Medical Genetics. Part A 140(14): 1542-1552, 2006

Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient. Proceedings of the National Academy of Sciences of the United States of America 90(11): 5186-5190, 1993

Bile salt export pump deficiency: A de novo mutation in a child compound heterozygous for ABCB11. Laboratory investigation to study pathogenic role and transmission of two novel ABCB11 mutations. Hepatology Research 43(3): 315-319, 2013

The first confirmed case with C3 deficiency caused by compound heterozygous mutations in the C3 gene; a new aspect of pathogenesis for C3 deficiency. Blood Cells, Molecules & Diseases 40(3): 410-413, 2008

Novel compound heterozygous mutations in the C3 gene: hereditary C3 deficiency. Pediatrics International 53(2): E16-E19, 2011